Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
DISCIPLINED GROWTH INVESTORS INC /MN DV DoubleVerify Holdings, Inc. 13G 6.3% 3mo
CVI Investments, Inc. NBRG Newbridge Acquisition Ltd 13G/A 4.9% 3mo
Legal & General Group Plc FSLY Fastly, Inc. 13G/A 2.8% 3mo
CVI Investments, Inc. CTXR Citius Pharmaceuticals, Inc. 13G/A 9.9% 3mo
THOMAS N. TRKLA YSWY Yesway, Inc. 13G 74.2% 3mo
Fort Baker Capital Management LP BBCQ Bleichroeder Acquisition Corp. II 13G 7.2% 3mo
BIOTECHNOLOGY VALUE FUND L P TENX Tenax Therapeutics, Inc. 13G/A 9.99% 3mo
Karpus Management, Inc. FIGX FIGX Capital Acquisition Corp. 13G 6% 3mo
Balyasny Asset Management L.P. NERV Minerva Neurosciences, Inc. 13G/A 9.99% 3mo
Global X Management CO LLC IIIN Insteel Industries Inc 13G/A 6.25% 3mo
Nextech VI Oncology SCSp TYRA Tyra Biosciences, Inc. 13G/A 6% 3mo
First Trust Capital Management L.P. CUB Lionheart Holdings 13G/A 3.7% 3mo
Harraden Circle Investments, LLC APUR Aperture AC 13G/A 0% 3mo
Blumenthal Neil Harris WRBY Warby Parker Inc. 13G/A 7.2% 3mo
ALLIANCEBERNSTEIN L.P. BCAL California BanCorp CA 13G/A 6.1% 3mo
GLENVIEW CAPITAL MANAGEMENT, LLC GTM ZoomInfo Technologies Inc. 13G/A 0% 3mo
VAN ECK ASSOCIATES CORP UAMY United States Antimony Corp 13G/A 5.8% 3mo
CVI Investments, Inc. APVO Aptevo Therapeutics Inc. 13G/A 6.3% 3mo
BAMCO INC /NY/ BIRK Birkenstock Holding plc 13G/A 8.01% 3mo
Nantahala Capital Management, LLC ADCT ADC Therapeutics SA 13G 9.69% 3mo
NOVO HOLDINGS A/S COAG Hemab Therapeutics Holdings, Inc. 13G 9% 3mo
COHEN & STEERS, INC. APC ARKO Petroleum Corp. 13G/A 8.68% 3mo
CITADEL ADVISORS LLC BOLD Boundless Bio, Inc. 13G/A 0.6% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ RVTY Revvity, Inc. 13G/A 5% 3mo
Pentwater Capital Management LP OGN Organon & Co. 13G 6.9% 3mo
Deep Track Capital, LP ENGN enGene Therapeutics Inc. 13G/A 0% 3mo
Empyrean Capital Partners, LP OPTU Optimum Communications, Inc. 13G/A 8.09% 3mo
OnePointTwo Capital Ventures LLC CNXU Conexeu Sciences Inc. 13G 6.8% 3mo
PERCEPTIVE ADVISORS LLC NVNO enVVeno Medical Corp 13G/A 3.5% 3mo
Alyeska Investment Group, L.P. QMCO Quantum Corp 13G 6.74% 3mo
Nantahala Capital Management, LLC AZTR Azitra, Inc. 13G 9.99% 3mo
Lynwood Capital Management Inc. KZIA Kazia Therapeutics Ltd 13G/A 4.6% 3mo
Global X Management CO LLC GEL Genesis Energy LP 13G/A 6.32% 3mo
Two Seas Capital LP QMCO Quantum Corp 13G 6.3% 3mo
ARMISTICE CAPITAL, LLC BCYC Bicycle Therapeutics PLC 13G/A 6.72% 3mo
American Century Investment Management, Inc. ODC Oil-Dri Corp of America 13G 5.2% 3mo
AMERIPRISE FINANCIAL INC VRRM VERRA MOBILITY Corp 13G 6.1% 3mo
Vivo Opportunity Fund Holdings, L.P. SABS SAB Biotherapeutics, Inc. 13G/A 9.99% 3mo
Fourthstone LLC CCFN MUNCY COLUMBIA FINANCIAL Corp 13G 7.8% 3mo
Squadron Capital Management LLC LPCN Lipocine Inc. 13G/A 9.8% 3mo
Pentwater Capital Management LP MASI Masimo Corp 13G/A 0% 3mo
SOROS FUND MANAGEMENT LLC KDK Kodiak AI, Inc. 13G/A 4.9% 3mo
METEORA CAPITAL, LLC KRAQ KRAKacquisition Corp 13G/A 6.14% 3mo
Two Seas Capital LP CLMT Calumet, Inc. 13G/A 7.5% 3mo
Magnetar Financial LLC WHLR Wheeler Real Estate Investment Trust, Inc. 13G/A 45% 3mo
AMERIPRISE FINANCIAL INC DEC Diversified Energy Co 13G/A 6.3% 3mo
Caligan Partners LP SABS SAB Biotherapeutics, Inc. 13G/A 8.8% 3mo
T. Rowe Price Investment Management, Inc. RVTY Revvity, Inc. 13G/A 16.4% 3mo
American Century Investment Management, Inc. HOG Harley-Davidson, Inc. 13G 5.1% 3mo
T. Rowe Price Investment Management, Inc. XPRO Expro Ltd 13G/A 5% 3mo